Craig-Hallum analyst Alex Fuhrman initiated coverage of LifeVantage (LFVN) with a Buy rating and $35 price target
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LFVN:
- LifeVantage announces results of third-party cell study of health weight stack
- LifeVantage launches 2025 vision with ‘Drive ERA’
- LifeVantage price target raised to $30 from $26 at Lake Street
- Exxon and Shell cautious on Q4, Flutter cuts guidance: Morning Buzz
- Morning Movers: AngioDynamics jumps following results and guidance raise